Clinical and Immunological Outcomes in High-Risk Resected Melanoma Patients Receiving Peptide-Based Vaccination and Interferon Alpha, With or Without Dacarbazine Preconditioning: A Phase II Study

Clinical studies based on novel rationales and mechanisms of action of chemotherapy agents and cytokines can contribute to the development of new concepts and strategies of antitumor combination therapies. In previous studies, we investigated the paradoxical immunostimulating effects of some chemoth...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Front Oncol
Autors principals: Urbani, Francesca, Ferraresi, Virginia, Capone, Imerio, Macchia, Iole, Palermo, Belinda, Nuzzo, Carmen, Torsello, Angela, Pezzotti, Patrizio, Giannarelli, Diana, Pozzi, Anna Fausta, Santaquilani, Mariano, Roazzi, Paolo, Bastucci, Silvia, Catricalà, Caterina, La Malfa, Antonia, Vercillo, Giuseppe, Gualtieri, Novella, Buccione, Carla, Castiello, Luciano, Cognetti, Francesco, Nisticò, Paola, Belardelli, Filippo, Moschella, Federica, Proietti, Enrico
Format: Artigo
Idioma:Inglês
Publicat: Frontiers Media S.A. 2020
Matèries:
Oncology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7069350/
https://ncbi.nlm.nih.gov/pubmed/32211314
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2020.00202
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars